Tmunity Therapeutics logo

Tmunity Therapeutics

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

5

Funding Rounds

$425.0m

Money raised

Overview

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

Funding

Funding series

Funding Series Analysis

The company Tmunity Therapeutics has raised a total of $275m in funding over 5 rounds.

Key Insights:

  • Tmunity Therapeutics Incorporated Series B round, October 2029: $75m
  • Tmunity Therapeutics Incorporated Series A round, January 2018: $100m
  • Tmunity Therapeutics Series A round, January 2018: $100m
  • Tmunity Therapeutics, Inc. funding round, October 2019: $75m
  • Tmunity Therapeutics funding round, November 2019: $75m
Tmunity Therapeutics logo
Tmunity Therapeutics Incorporated Series B round, October 2029 $75m
Tmunity Therapeutics logo
Tmunity Therapeutics Incorporated Series A round, January 2018 $100m
Tmunity Therapeutics logo
Tmunity Therapeutics Series A round, January 2018 $100m
Tmunity Therapeutics logo
Tmunity Therapeutics, Inc. funding round, October 2019 $75m
Tmunity Therapeutics logo
Tmunity Therapeutics funding round, November 2019 $75m

Industries

Tmunity Therapeutics is active in the following industries:
  • Immunotherapy
  • Healthcare
  • Cell therapy
  • Biomedical engineering
  • Biopharmaceutical
  • Cancer
  • Oncology
  • Consumer biotechnology
  • Engineering
  • Technology
  • Biology
  • Biotechnology
  • Internal medicine
  • Regenerative medicine
  • Medicine
  • Genomics
  • Genome editing
  • T cell